Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ...

In the next step, the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters.

Read the paper: Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial CTCs can travel through the bloodstream either individually or as ...

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients. The study is published in ...

Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases ...

Relationship between PD-L1 expression and the number of biopsy specimens in advanced gastric cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...

Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases.

Introduction: Circulating tumor cells (CTCs) have attracted significant interest as a biomarker for cancer diagnosis. In this study, we judiciously constructed a recombinant MUC1-dependent adenovirus ...

Cancer Check Labs is live in 44 states and has the ability to test for any solid tumor with a 40 ml blood draw.